Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing Escherichia coli in South Asia

Abstract

Aim: To determine the prevalence of extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL)-producing Escherichia coli in South Asia. Methodology: A systematic review and meta-analysis of data published in PubMed, EMBASE, Web of Science and Scopus. Results: The pooled prevalence of ESBL and MBL-producing E. coli in South Asia were 33% (95% CI: 27–40%) and 17% (95% CI: 12–24%), respectively. The prevalence of blaCTX-M type was 58% (95% CI: 49–66%) with blaCTX-M-15 being the most prevalent (51%, 95% CI: 40–62%) variant. The most prevalent MBL variant was blaNDM-1 (33%, 95% CI: 20–50%). Conclusion: This study suggests a high prevalence of ESBLs and MBLs among E. coli clinical isolates. Comprehensive resistance surveillance is required to guide clinicians prescribing antibiotics in South Asia.